CEACAM5 and cholangiocarcinoma: So far, carcinoembryonic antigen (CEA) and carbohydrate antigen 19-9 (CA19-9) are commonly applied for the diagnosis and management of CCA in patients with an elevation of serum hepatic and biliary markers.